MENU

RGNX REGENXBIO Forecast, Technical & Fundamental Analysis

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments... Show more

Industry: #Biotechnology
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

RGNX is expected to report earnings to rise 47.32% to -91 cents per share on March 02

REGENXBIO RGNX Stock Earnings Reports
Q4'26
Est.
$-0.91
Q3'26
Beat
by $0.73
Q2'26
Beat
by $0.18
Q1'26
Missed
by $0.38
Q4'25
Missed
by $0.58
The last earnings report on November 05 showed earnings per share of -62 cents, beating the estimate of -135 cents. With 7.57K shares outstanding, the current market capitalization sits at 503.02M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDS634.33-17.27
-2.65%
Dillards
VALU42.73-1.53
-3.46%
Value Line
SSMR14.07-0.73
-4.93%
Sunshine Silver Mining & Refining Co
KLRS1.87-0.43
-18.70%
Kalaris Therapeutics Inc
WHLR0.32-0.09
-21.71%
Wheeler Real Estate Investment Trust Inc

RGNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-4.71%
BEAM - RGNX
50%
Loosely correlated
-6.92%
AXON - RGNX
48%
Loosely correlated
-0.21%
RCKT - RGNX
48%
Loosely correlated
-3.16%
PRME - RGNX
46%
Loosely correlated
-9.30%
CRSP - RGNX
46%
Loosely correlated
-9.77%
More
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
371
Web
https://www.regenxbio.com
REGENXBIO (RGNX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com